1. Home
  2. ITP vs XBIO Comparison

ITP vs XBIO Comparison

Compare ITP & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

HOLD

Current Price

$0.19

Market Cap

4.0M

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.81

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITP
XBIO
Founded
1996
N/A
Country
China
United States
Employees
N/A
2
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
5.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ITP
XBIO
Price
$0.19
$2.81
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
150.0K
23.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
1.01
N/A
EPS
N/A
N/A
Revenue
$75,837,943.00
N/A
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.90
52 Week High
$1.00
$13.93

Technical Indicators

Market Signals
Indicator
ITP
XBIO
Relative Strength Index (RSI) 38.03 63.54
Support Level $0.16 $2.59
Resistance Level $0.22 $3.21
Average True Range (ATR) 0.01 0.18
MACD -0.00 0.04
Stochastic Oscillator 46.38 79.64

Price Performance

Historical Comparison
ITP
XBIO

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: